Biotechnology, widely believed to be “the next technological frontier,” is experiencing dynamic growth in Argentina. The nation’s R&D expenditures exceed $80 million, compatible with those of countries of intermediate economic development (many of which have a per capita GDP above that of Argentina). Argentina produces 14 percent of the world’s biotech crops, making it the third largest producer after the United States and Brazil. Its 200+ biotech firms earn well over $2 billion and cover sectors such as human health, animal health, food processing, and agriculture. Despite the economic and political volatility in Argentina in recent decades, biotech firms have suffered very few failures and have attracted interest from the leading investment groups in the country.

In a new report, Global Fellow Jerry Haar discusses the ecosystem of biotechnology in Argentina, its structure and dynamics, and offers policy recommendations for the country to continue its role as a regional leader in the field.

Download the paper